Correlation Between Humana and GRI Bio
Can any of the company-specific risk be diversified away by investing in both Humana and GRI Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Humana and GRI Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Humana Inc and GRI Bio, you can compare the effects of market volatilities on Humana and GRI Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Humana with a short position of GRI Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Humana and GRI Bio.
Diversification Opportunities for Humana and GRI Bio
Good diversification
The 3 months correlation between Humana and GRI is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Humana Inc and GRI Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GRI Bio and Humana is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Humana Inc are associated (or correlated) with GRI Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GRI Bio has no effect on the direction of Humana i.e., Humana and GRI Bio go up and down completely randomly.
Pair Corralation between Humana and GRI Bio
Considering the 90-day investment horizon Humana Inc is expected to under-perform the GRI Bio. But the etf apears to be less risky and, when comparing its historical volatility, Humana Inc is 2.73 times less risky than GRI Bio. The etf trades about -0.34 of its potential returns per unit of risk. The GRI Bio is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest 64.00 in GRI Bio on September 21, 2024 and sell it today you would earn a total of 13.00 from holding GRI Bio or generate 20.31% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Humana Inc vs. GRI Bio
Performance |
Timeline |
Humana Inc |
GRI Bio |
Humana and GRI Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Humana and GRI Bio
The main advantage of trading using opposite Humana and GRI Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Humana position performs unexpectedly, GRI Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GRI Bio will offset losses from the drop in GRI Bio's long position.Humana vs. Elevance Health | Humana vs. Centene Corp | Humana vs. UnitedHealth Group Incorporated | Humana vs. CVS Health Corp |
GRI Bio vs. Agilent Technologies | GRI Bio vs. Equillium | GRI Bio vs. 23Andme Holding Co | GRI Bio vs. DiaMedica Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |